DrugPatentWatch Database Preview
Blue Earth Company Profile
What is the competitive landscape for BLUE EARTH, and what generic alternatives to BLUE EARTH drugs are available?
BLUE EARTH has one approved drug.
There are three US patents protecting BLUE EARTH drugs.
There are thirty-five patent family members on BLUE EARTH drugs in fifteen countries.
Summary for Blue Earth
| International Patents: | 35 |
| US Patents: | 3 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Blue Earth
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Blue Earth | AXUMIN | fluciclovine f-18 | SOLUTION;INTRAVENOUS | 208054-001 | May 27, 2016 | RX | Yes | Yes | 9,387,266 | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Blue Earth | AXUMIN | fluciclovine f-18 | SOLUTION;INTRAVENOUS | 208054-001 | May 27, 2016 | RX | Yes | Yes | 5,808,146 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Blue Earth | AXUMIN | fluciclovine f-18 | SOLUTION;INTRAVENOUS | 208054-001 | May 27, 2016 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Blue Earth | AXUMIN | fluciclovine f-18 | SOLUTION;INTRAVENOUS | 208054-001 | May 27, 2016 | RX | Yes | Yes | 1,001,063 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Non-Orange Book US Patents for Blue Earth
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 8,758,724 | Unnatural amino acid radiolabeling precursor | ➤ Try a Free Trial |
| 5,817,776 | Amino acid analogs for tumor imaging | ➤ Try a Free Trial |
| 9,381,259 | Precursor compound of radioactive halogen-labeled organic compound | ➤ Try a Free Trial |
| Patent No. | Title | Estimated Patent Expiration |
International Patents for Blue Earth Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Israel | 235029 | ➤ Try a Free Trial |
| South Korea | 101643991 | ➤ Try a Free Trial |
| World Intellectual Property Organization (WIPO) | 2007063824 | ➤ Try a Free Trial |
| Japan | 2000500442 | ➤ Try a Free Trial |
| Norway | 341981 | ➤ Try a Free Trial |
| China | 101316812 | ➤ Try a Free Trial |
| South Korea | 20140108350 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.
